Report Categories
View AllRecent Articles
View All
STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session
Live LYV vs Competition Live misses Q4 EPS estimates by 4 as loss widens
GLIBA GCI slides 18 on shock Q1 miss as earnings fall 64 short of expectations alarming Wall Street
ANIK Anika Q1 earnings crush estimates by 265 but shares barely budge amid revenue softness